Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors
US8946230B2 · kind B2 · utility
4Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2011 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | May 9, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aryl- and heteroaryl-nitrogen heterocyclic compounds of formula (I):or a pharmaceutically acceptable salt thereof, wherein m, p, q, R1, R2, R3, X1, X2, X3, Y1 and Y2 are defined herein; and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, obsessive-compulsive disorder, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.